WASHINGTON, D.C. – Scott Whitaker, President and CEO of the Advanced Medical Technology Association® (AdvaMed®), issued the following statement today on CMS’s release of final CY 2020 Medicare payment rules…
WASHINGTON, D.C. – The Advanced Medical Technology Association® (AdvaMed®) issued a statement today from President and CEO Scott Whitaker regarding President Trump’s nomination of Dr. Stephen Hahn to serve as FDA Commissioner.
WASHINGTON, DC. – The Advanced Medical Technology Association® (AdvaMed®) was named one of the most effective trade associations in Washington, DC, according to the latest annual TradeMarks study released by…
WASHINGTON, DC. – A top FDA official warned that additional closures of ethylene oxide (EtO) sterilization plants could lead to shortages of critical medical devices across the country.
Medela LLC, headquartered in McHenry, Illinois, today wrote to Illinois state house speaker Michael Madigan saying they “respectfully oppose HB 3888 and HB 3885 because their restriction to EO use would…
WASHINGTON, D.C. – AdvaMed® released a statement on FDA’s announcement today that the agency is concerned about medical device shortages in light of two recent closures of ethylene oxide sterilization…
The closure of medical device sterilization facilities will disrupt the health care supply chain in every state and territory in the US and cause serious public health consequences that will…
WASHINGTON, D.C. – This week, six leading medical groups sent a letter to FDA urging caution as regulators consider limiting the use of ethylene oxide (EtO) for medical device sterilization. The surgeons…
WASHINGTON, D.C. – Scott Whitaker, president and CEO of AdvaMed®, today released a statement on Georgia’s filing of a temporary restraining order against BD’s medical device sterilization plant in Covington, Ga.
The Institute for Supply Management’s recently released September purchasing managers’ index – a key gauge of U.S. manufacturing strength – fell to its lowest reading in more than 10 years.…